Biogen Idec (NASDAQ:BIIB)

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alibaba, Anadarko, Beyond Meat, Boeing, Ctrip.com, GW Pharma, Roku, Texas Instruments, Veeco and More

Stocks were indicated to open lower on Tuesday, but nowhere close to the opening bell drop indications seen on Monday's "sell China" day. With many investors wondering if they should ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, April 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

Big Biotechs Confound Short Sellers

The short interest data are out for the most recent settlement date, March 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Big Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, March 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial

A Biogen Inc. (NASDAQ: BIIB) filing with the Securities and Exchange Commission (SEC) indicates that it intends to buy back a sizable amount of stock. This comes after the biotech ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Best Buy, Biogen, Booking, China Mobile, Chipotle, CNOOC, Kinder Morgan, Lumentum, MongoDB, Nike and More

Stocks were indicated to open lower on Friday, giving back most of the prior day's FOMC-delayed reaction rally. Now that the stock market has recovered so much in 2019, investors ...
Read Full Story »

Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?

Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer's disease after shares of Biogen Inc. (NASDAQ: BIIB) suffered handily with the announcement that it ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

March 21, 2019: The S&P 500 closed up 1.1% at 2,854.99. The DJIA closed up 0.9% at 25,963.77. Separately, the Nasdaq closed up 1.4% at 7,838.96. Thursday was a very ...
Read Full Story »

Why This Alzheimer’s Study Is Crushing Biogen Shares

Biogen Inc. (NASDAQ: BIIB) shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for Alzheimer’s disease. Specifically, the firm is discontinuing ...
Read Full Story »

Major Biotechs See a Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, February 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Are Nightstar Shareholders Getting Enough in the Buyout?

Nightstar Therapeutics PLC (NASDAQ: NITE) shares exploded early on Monday after it was announced that the firm would be acquired by Biogen Inc. (NASDAQ: BIIB). The transaction is expected to ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

Stocks were indicated to open higher by over 100 points on the Dow Jones industrial average and 10 points on the S&P 500 on developing China trade hopes. With the ...
Read Full Story »